Low-dose dexamethasone suppression test in chronic fatigue syndrome and health

Psychosomatic Medicine

Volumn 64, Issue 2, 2002, Pages 311-318

  Gaab, Jens ^a,b   Hüster, Dominik ^a   Peisen, Renate ^a   Engert, Veronika ^a   Schad, Tanja ^a   Schürmeyer, Thomas H ^a   Ehlert, Ulrike ^a  

^a UNIVERSITY OF TRIER   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Chronic fatigue syndrome; Dexamethasone; HPA axis; Salivary cortisol

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE;

ADULT; AROUSAL; ARTICLE; CHRONIC FATIGUE SYNDROME; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; DEXAMETHASONE SUPPRESSION TEST; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MENTAL STRESS; NEGATIVE FEEDBACK; PATHOGENESIS; PRIORITY JOURNAL; SALIVA LEVEL;

EID: 0036203639     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006842-200203000-00015     Document Type: Article

References (58)

1. The chronic fatigue syndrome: A comprehensive approach to its definition and study
2. The psychobiology of chronic fatigue syndrome: The central nervous system as a common pathway
3. Mild adrenocortical deficiency, chronic allergies, autoimmune disorders and the chronic fatigue syndrome: A continuation of the cortisone story
4. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders
5. Hypoadrenia or "a bit of Addison's disease"
6. Salivary cortisol profiles in chronic fatigue syndrome
7. The 1 microg short Synacthen test in chronic fatigue syndrome
8. Urinary free cortisol excretion in chronic fatigue syndrome, major depression and in healthy volunteers
9. Blunted adrenocorticotropin and cortisol responses to corticotropin-releasing hormone stimulation in chronic fatigue syndrome
10. The low dose ACTH test in chronic fatigue syndrome and in health
11. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome
12. Chronic pain and fatigue syndromes: Overlapping clinical and neuroendocrine features and potential pathogenic mechanisms
13. The endocrinology of melancholic and atypical depression: Relation to neurocircuitry and somatic consequences
14. Brain corticosteroid receptor balance in health and disease
15. Depression in patients with neuromyasthenia (benign myalgic encephalomyelitis)
16. Self-perceived fatigue and cortisol secretion in a community sample
17. Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome
18. The dexamethasone suppression test in fibrositis
19. Diurnal hormone variation in fibromyalgia syndrome: A comparison with rheumatoid arthritis
20. Neuroendocrinologic findings in primary fibromyalgia (soft tissue chronic pain syndrome) and in other chronic rheumatic conditions (rheumatoid arthritis, low back pain)
21. Contrasting neuroendocrine responses in depression and chronic fatigue syndrome
22. Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder
23. Effect of high plasma dexamethasone levels on DST sensitivity: Dose-response study in depressed patients and controls
24. Tissue specificity of glucocorticoid sensitivity in healthy adults
25. A report - Chronic fatigue syndrome: Guidelines for research
26. Dimensional assessment of chronic fatigue syndrome
27. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue
28. Assessing health in musculoskeletal disorders - The appropriateness of a German version of the Sickness Impact Profile
29. Free cortisol levels after awakening: A reliable biological marker for the assessment of adrenocortical activity
30. Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement
31. Dexamethasone bioavailability: Implications for DST research
32. Dexamethasone metabolism in dexamethasone suppression test suppressors and nonsuppressors
33. Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder
34. Basal cortisol, dexamethasone suppression of cortisol, and MHPG in adolescents after the 1988 earthquake in Armenia
35. Enhanced dexamethasone suppression of plasma cortisol in adult women traumatized by childhood sexual abuse
36. Chronic fatigue in the community: 'A question of attribution'
37. Attributions and self-esteem in depression and chronic fatigue syndromes
38. Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitaryadrenal axis
39. The cortisol response to awakening in relation to different challenge tests and a 12-hour cortisol rhythm
40. Burnout, perceived stress, and cortisol responses to awakening
41. Abuse-related posttraumatic stress disorder and alterations of the hypothalamic-pituitary-adrenal axis in women with chronic pelvic pain
42. Increased pituitary activation following metyrapone administration in post-traumatic stress disorder
43. Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder
44. Critical life events, infections, and symptoms during the year preceding chronic fatigue syndrome (CFS): An examination of CFS patients and subjects with a nonspecific life crisis
45. Precipitating factors for the chronic fatigue syndrome
46. Victimization in fibromyalgia and chronic fatigue syndrome in tertiary care: A controlled study on prevalence and characteristics
47. Adult health status of women with histories of childhood abuse and neglect
48. Stress-restress: Effects on ACTH and fast feedback
49. Differential regulation of hippocampal glucocorticoid receptors mRNA and fast feedback: Relevance to post-traumatic stress disorder
50. Why dexamethasone poorly penetrates in brain
51. Dexamethasone suppression of corticosteroid secretion: Evaluation of the site of action by receptor measures and functional studies
52. Corticosterone regulation of type I and type II adrenal steroid receptors in brain, pituitary, and immune tissue
53. Increased sensitivity to glucocorticoids in peripheral blood mononuclear cells of chronic fatigue syndrome patients, without evidence for altered density or affinity of glucocorticoid receptors
54. Chronic fatigue syndrome and depression: Conceptual and methodological ambiguities